Macrolides | Prodrugs | Antimalarials | Unit 2 Medicinal Chemistry 6th Semester
This is a comprehensive lecture covering Unit 2 of 6th semester Medicinal Chemistry, focusing on Macrolides (bacteriostatic antibiotics), Prodrugs (inactive drugs converted to active forms in the body), and Antimalarials (drugs treating malaria caused by Plasmodium parasites).
Summary
The lecture comprehensively covers Unit 2 of 6th semester Medicinal Chemistry, divided into four main sections. First, it discusses Macrolides, which are bacteriostatic antibiotics derived from Streptomyces species. The speaker explains that macrolides get their name from their large lactone ring structure (14-16 carbons) with attached sugar groups like desosamine and cladinose. The mechanism involves binding to the 50s ribosomal unit and blocking translocation of tRNA from A-site to P-site, ultimately halting protein synthesis. Key drugs include erythromycin, clarithromycin, and azithromycin. The second section covers miscellaneous antibiotics, particularly chloramphenicol (a star drug) which also binds to 50s ribosomal units but works by inhibiting peptide bond formation rather than tRNA translocation. A detailed synthesis of chloramphenicol is provided starting from para-nitro acetophenone. The third major section focuses on Prodrugs - inactive or less active drugs that require biotransformation to become pharmacologically active. These are designed to improve solubility, stability, absorption, reduce toxicity, or provide targeted delivery. Prodrugs are classified as carrier-linked (with removable carriers) or bioprecursors (involving structural changes). The final section covers Antimalarials, explaining the malaria lifecycle involving Plasmodium parasites transmitted by female Anopheles mosquitoes. The lifecycle alternates between human (asexual) and mosquito (sexual) stages. Antimalarial drugs are classified into quinolines (including 4-aminoquinolines and 8-aminoquinolines), biguanides, dihydrotriazines, and miscellaneous drugs, each with specific mechanisms targeting different stages of the parasite lifecycle.
Key Insights
- The speaker explains that macrolides work by binding to the 50s ribosomal unit and blocking tRNA translocation from A-site to P-site, preventing protein synthesis in bacteria
- The instructor describes prodrugs as chemically modified drug molecules that are inactive in their administered form but require biotransformation to become pharmacologically active
- The lecturer explains that malaria parasites utilize hemoglobin as a source of amino acids, releasing toxic heme which they convert to non-toxic hemozoin, and antimalarial drugs work by inhibiting this conversion
- The speaker clarifies that only female Anopheles mosquitoes can transmit malaria, and the disease involves complex lifecycle stages alternating between human and mosquito hosts
- The instructor details that chloramphenicol synthesis involves multiple steps starting from para-nitro acetophenone, emphasizing this as an important star drug with detailed synthetic pathway
Topics
Full transcript available for MurmurCast members
Sign Up to Access